Klaus Koefoed

1.9k total citations
17 papers, 590 citations indexed

About

Klaus Koefoed is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Klaus Koefoed has authored 17 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Klaus Koefoed's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and HER2/EGFR in Cancer Research (4 papers). Klaus Koefoed is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and HER2/EGFR in Cancer Research (4 papers). Klaus Koefoed collaborates with scholars based in Denmark, United States and Canada. Klaus Koefoed's co-authors include Mikkel W. Pedersen, Michael Kragh, Helle J. Jacobsen, John S. Haurum, Charles Pyke, Adam Hey, Ivan D. Horak, Johan Lantto, Thomas T. Poulsen and Anna Dahlman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Klaus Koefoed

17 papers receiving 562 citations

Peers

Countries citing papers authored by Klaus Koefoed

Since Specialization

Citations

This map shows the geographic impact of Klaus Koefoed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Koefoed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Koefoed more than expected).

Fields of papers citing papers by Klaus Koefoed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Koefoed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Koefoed. The network helps show where Klaus Koefoed may publish in the future.

Co-authorship network of co-authors of Klaus Koefoed

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Koefoed. A scholar is included among the top collaborators of Klaus Koefoed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Koefoed. Klaus Koefoed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster 2023 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anne Worsaae, (unknown), (unknown), (unknown), Anna Karina Juhl, Torben Gjetting, Lars Østergaard, Amédée des Georges, (unknown), Mariane Høgsbjerg Schleimann, Klaus Koefoed, Martin Tolstrup	1
2	Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform 2019 ·mAbs ·Torben Gjetting, Monika Gad, Camilla Fröhlich, Trine Lindsted, Maria C. Melander, Vikram Bhatia, Michael M. Grandal, Nikolaj Dietrich, Franziska Uhlenbrock, Gunther R. Galler, Magnus Strandh, Johan Lantto, Thomas Bouquin, Ivan D. Horak, Michael Kragh, Mikkel W. Pedersen, Klaus Koefoed	25
3	The E3 ubiquitin ligase SMURF1 regulates cell-fate specification and outflow tract septation during mammalian heart development 2018 ·Scientific Reports ·Klaus Koefoed, (unknown), Peter Andersen, (unknown), Melanie Pye, Troels Andersen, (unknown), Eske Bendsen, Masahiro Narimatsu, Frederik Vilhardt, Lotte B. Pedersen, Jeffrey L. Wrana, Robert H. Anderson, Kjeld Møllgård, Søren T. Christensen, Lars Allan Larsen	21
4	Abstract 5629: Preclinical characterization of Sym023 a human anti-TIM3 antibody with a novel mechanism of action 2018 ·Cancer Research ·Trine Lindsted, Monika Gad, Michael V. Grandal, (unknown), Vikram Bhatia, Torben Gjetting, Johan Lantto, Ivan D. Horak, Michael Kragh, Klaus Koefoed, Mikkel W. Pedersen	12
5	Sym015: A Highly Efficacious Antibody Mixture against MET -Amplified Tumors 2017 ·Clinical Cancer Research ·Thomas T. Poulsen, Michael M. Grandal, (unknown), (unknown), (unknown), Klaus Koefoed, Trine Lindsted, Camilla Fröhlich, (unknown), Karsten W. Eriksen, Anna Dahlman, Helle J. Jacobsen, Thomas Bouquin, Mikkel W. Pedersen, Ivan D. Horak, Johan Lantto, Michael Kragh	42
6	Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms 2017 ·Molecular Cancer Therapeutics ·Michael M. Grandal, (unknown), Thomas T. Poulsen, Klaus Koefoed, Anna Dahlman, Gunther R. Galler, Paolo Conrotto, Sara Collins, Karsten W. Eriksen, Dafna Kaufman, George F. Vande Woude, Helle J. Jacobsen, Ivan D. Horak, Michael Kragh, Johan Lantto, Thomas Bouquin, Morag Park, Mikkel W. Pedersen	23
7	Genotyping circulating tumor DNA identifies metastatic colorectal cancer (mCRC) patients highly sensitive to Sym004 2017 ·Annals of Oncology ·(unknown), Alberto Bardelli, Thomas T. Poulsen, Rodrigo Dienstmann, Michael Kragh, Scott Kopetz, Klaus Koefoed, Fortunato Ciardiello, (unknown), Joana Vidal, Jenifer Clausell-Tormos, Giulia Siravegna, Trine Lindsted, Mikkel W. Pedersen, Giuseppe Rospo, (unknown), Paul I. Nadler, Ivan D. Horak, Josep Tabernero	1
8	Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity 2015 ·Clinical Cancer Research ·Helle J. Jacobsen, Thomas T. Poulsen, Anna Dahlman, (unknown), Klaus Koefoed, Jette W. Sen, Dietmar Weilguny, Bolette Bjerregaard, (unknown), Ivan D. Horak, Mikkel W. Pedersen, Michael Kragh, Johan Lantto	71
9	Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance 2015 ·Molecular Cancer Therapeutics ·Mikkel W. Pedersen, Helle J. Jacobsen, Klaus Koefoed, Anna Dahlman, (unknown), Thomas T. Poulsen, Per‐Johan Meijer, Lars S. Nielsen, Ivan D. Horak, Johan Lantto, Michael Kragh	42
10	Coordination of TGFβ/BMP signaling is associated with the primary cilium 2015 ·Europe PMC (PubMed Central) ·(unknown), (unknown), Klaus Koefoed, Johanne B. Mogensen, F Schmid, Lotte B. Pedersen, (unknown), Søren T. Christensen	7
11	Affinity Capture of Biotinylated Proteins at Acidic Conditions to Facilitate Hydrogen/Deuterium Exchange Mass Spectrometry Analysis of Multimeric Protein Complexes 2013 ·Analytical Chemistry ·Pernille Foged Jensen, Thomas J. D. Jørgensen, Klaus Koefoed, (unknown), Jette W. Sen	11
12	Combination of two anti‐CD5 monoclonal antibodies synergistically induces complement‐dependent cytotoxicity of chronic lymphocytic leukaemia cells 2013 ·British Journal of Haematology ·Josephine L. Klitgaard, Klaus Koefoed, Christian H. Geisler, Ole Gadeberg, David A. Frank, Jørgen Holm Petersen, Jesper Jurlander, Mikkel W. Pedersen	21
13	Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor 2011 ·mAbs ·Klaus Koefoed, Lucilla Steinaa, (unknown), (unknown), Helle J. Jacobsen, Per‐Johan Meijer, John S. Haurum, Allan Jensen, Michael Kragh, Peter S. Andersen, Mikkel W. Pedersen	76
14	Sym004: A Novel Synergistic Anti–Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy 2010 ·Cancer Research ·Mikkel W. Pedersen, Helle J. Jacobsen, Klaus Koefoed, Adam Hey, Charles Pyke, John S. Haurum, Michael Kragh	174
15	Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs 2005 ·Journal of Immunological Methods ·Klaus Koefoed, Lauge Farnaes, (unknown), Arne Svejgaard, Dennis R. Burton, Henrik J. Ditzel	9
16	Identification of talin head domain as an immunodominant epitope of the antiplatelet antibody response in patients with HIV-1-associated thrombocytopenia 2004 ·Blood ·Klaus Koefoed, Henrik J. Ditzel	11
17	The CCR5 receptor acts as an alloantigen in CCR5Δ32 homozygous individuals: Identification of chemokineand HIV-1-blocking human antibodies 1998 ·Proceedings of the National Academy of Sciences ·Henrik J. Ditzel, Mette M. Rosenkilde, Peter Garred, Meng Wang, Klaus Koefoed, Court Pedersen, Dennis R. Burton, Thue W. Schwartz	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact